Top

Published in:

01-09-2014 | Original Paper

Glutathione metabolism enzymes in brain and liver of hyperphenylalaninemic rats and the effect of lipoic acid treatment

Authors: Tarsila Barros Moraes, Giovana Reche Dalazen, Carlos Eduardo Jacques, Raylane Silva de Freitas, Andrea Pereira Rosa, Carlos Severo Dutra-Filho

Published in: Metabolic Brain Disease | Issue 3/2014

Abstract

Phenylketonuria (PKU) is a disorder caused by a deficiency in phenylalanine hydroxylase activity, which converts phenylalanine (Phe) to tyrosine, leading to hyperphenylalaninemia (HPA) with accumulation of Phe in tissues of patients. The neuropathophysiology mechanism of disease remains unknown. However, recently the involvement of oxidative stress with decreased glutathione levels in PKU has been reported. Intracellular glutathione (GSH) levels may be maintained by the antioxidant action of lipoic acid (LA). The aim of this study was to evaluate the activity of the enzymes involved in the metabolism and function of GSH, such as glutathione peroxidase (GSH-Px), glucose-6-phosphate dehydrogenase (G6PD), glutathione reductase (GR), glutamate-cysteine ligase (GCL), glutathione-S-transferase (GST) and GSH content in brain and liver of young rats subjected to a chemically induced model of HPA and the effect of LA for a week. In brain, the administration of Phe reduced the activity of the GSH-Px, GR and G6PD and LA prevented these effects totally or partially. GCL activity was increased by HPA and was not affect by LA antioxidant treatment. GST activity did not differ between groups. GSH content was increased by LA and decreased by HPA treatment in brain samples. Considering the liver, all parameters analyzed were increased in studied HPA animals and LA was able to hinder some effects except for the GCL, GST enzymes and GSH content. These results suggested that HPA model alter the metabolism of GSH in rat brain and liver, which may have an important role in the maintenance of GSH function in PKU although liver is not a directly affected organ in this disease. So, an antioxidant therapy with LA may be useful in the treatment of oxidative stress in HPA.

Abdin AA, Sarhan NI (2011) Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and l-dopa toxicity. Neurosci Res 71(4):387–395PubMedCrossRef

Artuch R, Colome C, Vilaseca MA et al (2001) Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria. J Inherit Metab Dis 24:359–366PubMedCrossRef

Aoyama K, Watabe M, Nakaki T (2008) Regulation of Neuronal Glutathione Synthesis. J Pharmacol Sci 108:227–238PubMed

Berti SL, Nasi GM, Garcia C, de Castro FL, Nunes ML, Rojas DB, Moraes TB, Dutra-Filho CS, Wannmacher CMD (2012) Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats. Metab Brain Dis 27:79–89PubMedCrossRef

Bilska A, Włodek L (2005) Lipoic acid - the drug of the future? Pharmacol Rep 57(5):570–577PubMed

Browne RW, Armstrong D (1998) Reduced glutathione and glutathione disulfide. Methods Mol Biol 108:347–352PubMed

Brigelius-Flohe´ R (1999) Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 27:951–965PubMedCrossRef

Calberg I, Manervik B (1985) Glutathione Reductase. Methods Enzymol 113:484–490CrossRef

Chung PM, Cappel RE, Gilbert HF (1991) Inhibition of glutathione disulfide reductase by glutathione. Arch Biochem Biophys 288(1):48–53PubMedCrossRef

de Souza GF, Saldanha GB, de Freitas RM (2010) Lipoic acid increases glutathione peroxidase, Na+, K + -atpase and acetylcholinesterase activities in rat hippocampus after pilocarpine-induced seizures? Arq Neuropsiquiatr 68(4):586–591PubMedCrossRef

Diamond A, Ciaramitaro V, Donner E, Djali S, Robinson MB (1994) An Animal Model of Early-treated PKU. J Neurosci 14(5):3072–3082PubMed

Dickinson DA, Forman HJ (2002) Cellular glutathione and thiols metabolism. Biochem Pharmacol 64:1019–1026PubMedCrossRef

Dickinson DA, Moellering DR, Iles KE et al (2003) Cytoprotection against oxidative stress and the regulation of glutathione synthesis. Biol Chem 384:527–537PubMedCrossRef

dos Reis EA, Rieger E, de Souza SS, Rasia-Filho AA, Wannmacher CMD (2013) Effects of a co-treatment with pyruvate and creatine on dendritic spines in rat hippocampus and posterodorsal medial amygdala in a phenylketonuria animal model. Metab Brain Dis 28:509–517PubMedCrossRef

Ercal N, Aykin-Burns N, Gurer-Orhan H, Mcdonald JD (2002) Oxidative stress in a phenylketonuria animal model. Free Radic Biol Med 32:906–911PubMedCrossRef

Favilli F, Marraccini P, Iantomasi T, Vincenzini MT (1997) Effect of orally administered glutathione on glutathione levels in some organs of rats: role of specific transporters. Br J Nutr 78:293–300PubMedCrossRef

Fonseca RR, Johnson WE, O’Brien SJ et al (2010) Molecular evolution and the role of oxidative stress in the expansion and functional diversification of cytosolic glutathione transferases. BMC Evol Biol 10:281PubMedCentralPubMedCrossRef

Habig WH, Pabst MJ, Jacoby WB (1974) Glutathione S-Transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139PubMed

Hagen TM, Ingersoll RT, Lykkesfeldt J et al (1999) (R)-α-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. Faseb J 13:411–418PubMed

Huerta-Olvera SG, Macías-Barragán J, Ramos-Márquez ME et al (2010) Alpha-lipoic acid regulates heme oxygenase gene expression and nuclear Nrf2 activation as a mechanism of protection against arsenic exposure in HepG2 cells. Envir Toxicol Pharmacol 29:144–149CrossRef

Järvinen K, Soini Y, Kinnula VL (2003) γ-Glutamylcysteine Synthetase in Lung Cancer. Effect on Cell Viability. Methods Mol Med 74:211–222PubMed

Johnson WM, Wilson-Delfosse AL, Mieyal JJ (2012) Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases. Nutrients 4:1399–1440PubMedCentralPubMedCrossRef

Kienzle-Hagen ME, Pederzolli CD, Sgaravatti AM et al (2002) Experimental hyperphenylalaninemia provokes oxidative stress in rat brain. Biochim Biophys Acta 1586(3):344–352PubMedCrossRef

Kretzschmar M (1996) Regulation of hepatic glutathione metabolism and its role in hepatotoxicity. Exp Toxic Pathol 48:439–446CrossRef

Leong SF, Clark JB (1984) Regional enzyme development in rat brain. Enzymes associated with glucose utilization. Biochem J 218:131–138PubMedCentralPubMed

Lissi EA, Cáceres T, Videla LA (1986) Visible chemiluminescence from rat brain homogenates undergoing autoxidation. I. Effect of additives and products accumulation. Free Radic Biol Med 2(1):63–69CrossRef

Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the folin phenol. J Biol Chem 193:265–275PubMed

Lu SC (1999) Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J 13(10):1169–1183PubMed

Lu SC (2009) Regulation of glutathione synthesis. Mol Aspects Med 30(1–2):42–59PubMedCentralPubMedCrossRef

Luttges MW, Gerren RA (1979) Postnatal alpha-methylphenylalanine treatment effects on adult mouse locomotor activity and avoidance learning. Pharmacol Biochem Behav 11(5):493–498PubMedCrossRef

Mazzola PN, Karikas GA, Schulpis KH, Dutra-Filho CS (2013) Antioxidant treatment strategies for hyperphenylalaninemia. Metab Brain Dis. doi:10.1007/s11011-013-9414-2

Ookhtens O, Kaplowitz N (1998) Role of the liver in intergorgan homeostasis of glutathione and cyst(e)ine. Semin Liver Dis 18:313–329PubMedCrossRef

Packer L, Tritschler HJ, Wessel K (1997) Neuroprotection by the metabolic antioxidant α-lipoic acid. Free Rad Biol and Med 22:359–378

Pietz J (1998) Neurological aspects of adult phenylketonuria. Curr Opin Neurol 11:679–688PubMedCrossRef

Reed MC, Thomas RL, Pavisic J, James SJ, Ulrich CM, Nijhon HF (2008) A mathematical model of glutathione metabolism. Theor Biol Med Model 5:8. doi:10.1186/1742-4682-5-8 PubMedCentralPubMedCrossRef

Samuel S, Kathirvel R, Jayavelu T, Chinnakkannu P (2005) Protein oxidative damage in arsenic induced rat brain: influence of DL-α-lipoic acid. Toxicol Lett 155:27–34

Sanayama Y, Nagasaka H, Takayanagi M et al (2011) Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Mol Genet Metab 103(3):220–225PubMedCrossRef

Satoh T, McKercher SR, Lipton SA (2013) NrF2/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radic Biol Med. doi:10.1016/j.freeradbiomed.2013.07.022

Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1667–1724

Seybolt SEJ (2010) Is it time to reassess alpha lipoic acid and niacinamide therapy in schizophrenia? Med Hypotheses 75(6):572–575PubMedCrossRef

Singh S, Anand A, Srivastava PK (2012) Regulation and properties of glucose-6-phosphate dehydrogenase: A review. Int J Plant Physiol Biochem 4(1):1–19

Sirtori LR, Dutra-Filho CS, Fitarelli D et al (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740(1):68–73PubMedCrossRef

Sitta A, Barschak AG, Deon M et al (2006) Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis 21(4):287–296PubMedCrossRef

Sitta A, Barschak AG, Deon M et al (2009) Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients. Int J Dev Neurosci 27:243–247PubMedCrossRef

Sitta A, Vanzin CS, Biancini GB, Manfredini V, de Oliveira AB, Wayhs CA, Ribas GO, Giugliani L, Schwartz IV, Bohrer D, Garcia SC, Wajner M, Vargas CR (2011) Evidence that Lcarnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients. Cell Mol Neurobiol 31(3):429–436PubMedCrossRef

Suh JH, Shenvi SV, Dixon BM et al (2004) Decline in transcriptional activity of Nrf2 causes age related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci 101:3381–3386PubMedCentralPubMedCrossRef

Tateishi N, Higashi T, Naruse A, Nakashima K, Shiozaki H (1977) Rat liver glutathione: possible role as a reservoir of cysteine. J Nutr 107:51–60PubMed

Townsend DM, Manevich Y, He L, Hutchens S, Pazoles CJ, Tew KD (2008) Novel Role for Glutathione S-Transferase: Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 284(1):436–445PubMedCrossRef

Valdovinos-Flores C, Gosenbatt ME (2012) The role of amino acids transporters in GSH synthesis in the blood brain barrier and central nervous system. Neurochem Intern 61:405–414CrossRef

Vargas CR, Wajner M, Sitta A (2011) Oxidative stress in phenylketonuric patients. Mol Genet Metab 104:S97–S99PubMedCrossRef

Vilaseca MA, Lambruschini N, Gómez-López L et al (2010) Quality of dietary control in phenylketonuric patients and its relationship with general intelligence. Nutr Hosp 25:60–66PubMed

Wagner AE, Ernst IMA, Birringer M, Sancak Ö, Barella L, Rimbach G (2012) A Combination of Lipoic Acid Plus Coenzyme Q10 Induces PGC1α, a Master Switch of Energy Metabolism, Improves Stress Response, and Increases Cellular Glutathione Levels in Cultured C2C12 Skeletal Muscle Cells. Oxidative Med Cell Longev. doi:10.1155/2012/835970

Wendel A (1981) Glutathione peroxidase. Meth Enzymol 77:325–332PubMedCrossRef

White CC, Viernes H, Krejsa CM et al (2003) Fluorescence-based microtiter plate assay for glutamate–cysteine ligase activity. Anal Biochem 318:175–180PubMedCrossRef

Wojtkowiak-Giera A, Wandurska-Nowak E, Michalak M (2011) Changes in the activity and kinetics of mouse intestinal glutathione transferase during experimental trichinellosis. Parasitol Res 108:1309–1313PubMedCrossRef

Title: Glutathione metabolism enzymes in brain and liver of hyperphenylalaninemic rats and the effect of lipoic acid treatment
Authors: Tarsila Barros Moraes
Giovana Reche Dalazen
Carlos Eduardo Jacques
Raylane Silva de Freitas
Andrea Pereira Rosa
Carlos Severo Dutra-Filho
Publication date: 01-09-2014
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 3/2014
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-014-9491-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Glutathione metabolism enzymes in brain and liver of hyperphenylalaninemic rats and the effect of lipoic acid treatment

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Serum uric acid level is associated with the prevalence but not with survival of amyotrophic lateral sclerosis in a Chinese population

Aberrant interhemispheric functional coordination in patients with HBV-related cirrhosis and minimal hepatic encephalopathy

Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency

Myeloid-specific deletion of SIRT1 increases hepatic steatosis and hypothalamic inflammation in mice fed a high-fat diet

Brain metabolite clearance: impact on Alzheimer’s disease

Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery tests